Philippe Gajdos
Overview
Explore the profile of Philippe Gajdos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
680
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gajdos P, Chevret S, Toyka K
Cochrane Database Syst Rev
. 2012 Dec;
12:CD002277.
PMID: 23235588
Background: Myasthenia gravis is an autoimmune disease in which autoantibodies interfere with neuromuscular transmission. As with other autoimmune diseases, people with myasthenia gravis would be expected to benefit from intravenous...
2.
Annane D, Chadda K, Gajdos P, Jars-Guincestre M, Chevret S, Raphael J
Intensive Care Med
. 2010 Dec;
37(3):486-92.
PMID: 21125215
Introduction: Although hyperbaric oxygen therapy (HBO) is broadly used for carbon monoxide (CO) poisoning, its efficacy and practical modalities remain controversial. Objectives: To assess HBO in patients poisoned with CO....
3.
Brochon C, Caillaux M, Gajdos P
Rev Prat
. 2009 Nov;
59(8):1077-8.
PMID: 19894444
No abstract available.
4.
Vandiedonck C, Raffoux C, Eymard B, Tranchant C, Dulmet E, Krumeich S, et al.
J Neuroimmunol
. 2009 Mar;
210(1-2):120-3.
PMID: 19278738
We investigated an association of the HLA-A locus in 78 French Caucasian patients with autoimmune myasthenia gravis (MG) and thymic epithelial tumours. The largest effect was a protection associated with...
5.
Gajdos P, Chevret S
Ann N Y Acad Sci
. 2007 Dec;
1132:271-5.
PMID: 18096850
The results of four randomized controlled trials were examined to assess the efficacy of intravenous immunoglobulin (IVIG) for myasthenia gravis (MG) acute exacerbations. The first trial compared plasma exchange (PE)...
6.
Giraud M, Taubert R, Vandiedonck C, Ke X, Levi-Strauss M, Pagani F, et al.
Nature
. 2007 Aug;
448(7156):934-7.
PMID: 17687331
Promiscuous expression of tissue-restricted auto-antigens in the thymus imposes T-cell tolerance and provides protection from autoimmune diseases. Promiscuous expression of a set of self-antigens occurs in medullary thymic epithelial cells...
7.
Vandiedonck C, Capdevielle C, Giraud M, Krumeich S, Jais J, Eymard B, et al.
Ann Neurol
. 2006 Jan;
59(2):404-7.
PMID: 16437561
Objective: Our objective was to investigate a role of the intracellular tyrosine phosphatase PTPN22*R620W variant in autoimmune myasthenia gravis (MG), considering disease heterogeneity. Methods: We used a case-control design, comparing...
8.
Gajdos P, Tranchant C, Clair B, Bolgert F, Eymard B, Stojkovic T, et al.
Arch Neurol
. 2005 Nov;
62(11):1689-93.
PMID: 16286541
Background: The optimal dose of intravenous immunoglobulin (IVIG) in acute exacerbation of myasthenia gravis remains unknown. Increasing the treatment duration might provide added efficacy. Objective: To determine the optimal dose...
9.
Annane D, Depondt J, Aubert P, Villart M, Gehanno P, Gajdos P, et al.
J Clin Oncol
. 2004 Nov;
22(24):4893-900.
PMID: 15520052
Purpose: To determine the efficacy and safety of hyperbaric oxygen therapy (HBO) for overt mandibular osteoradionecrosis. Patients And Methods: This prospective, multicenter, randomized, double-blind, placebo-controlled trial was conducted at 12...
10.
Vandiedonck C, Beaurain G, Giraud M, Hue-Beauvais C, Eymard B, Tranchant C, et al.
Proc Natl Acad Sci U S A
. 2004 Oct;
101(43):15464-9.
PMID: 15489265
The 8.1 haplotype of the HLA complex has been reproducibly associated with several autoimmune diseases and traits, notably with thymus hyperplasia in patients with acquired generalized myasthenia gravis, an autoantibody-mediated...